Press Releases | ClavystBio

Press Releases

14 Oct 2026

Portfolio

Singapore Venture Creation Group 65LAB Awards US$1.69 million to A*STAR-led Project Targeting the Cause of Vision Loss in Glaucoma and NAION

08 Oct 2026

Portfolio

Nuevocor Doses First Patient in SUNBEAM-LMNA Phase 1/2 Trial and Receives FDA Fast Track Designation for NVC-001 in LMNA Dilated Cardiomyopathy

05 Oct 2026

Portfolio

Zenflow Secures $52M Series D Financing and Announces Exclusive U.S. Distribution Partnership with Cook Medical

30 Sep 2026

Portfolio

Hummingbird Bioscience Announces First Patient Dosed in Phase II Trial of HMBD-001 and Cetuximab in Advanced Squamous Cell Cancers

29 Sep 2026

Portfolio

Rejoni Receives FDA Approval of the Juveena® Hydrogel System to Reduce Intrauterine Adhesions Following Hysteroscopic Adhesiolysis

21 Sep 2026

Portfolio

Respiree Extends Series A Syndicate with Addition of International Investors to Support Continued Global Growth

15 Sep 2026

Portfolio

Hummingbird Bioscience Appoints Dr. James Garner as President

10 Sep 2026

Portfolio

Callio Therapeutics Appoints Zachary Hornby as Chief Executive Oﬃcer

09 Sep 2026

Portfolio

Leyden Labs Reports Positive Phase 1 Results for RIG-101, Supporting Advancement into Phase 2 to Protect Asthma Patients

26 Aug 2026

Portfolio

Paratus Sciences Announces Updates to its Board of Directors

Page

1 2 3 4 5

Stay in the Loop

Sign up to get the latest news on our innovation community and events.

Subscribe Now